- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07819617
Submental Island Flap vs Radial Forearm Free Flap in Tongue Reconstruction (SIPF-RFFF)
Evaluation of Quality of Life Post Tongue Cancer Resection and Reconstruction Using Submental Island Pedicled Flap Versus Radial Forearm Free Flap
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Surgical reconstruction following tongue cancer resection is essential for restoring oral function, speech, swallowing, and facial aesthetics. The Radial Forearm Free Flap (RFFF) is widely considered a gold standard for soft tissue oral reconstruction; however, it requires microvascular expertise and carries donor-site morbidity. The Submental Island Pedicled Flap (SIPF) serves as an alternative, offering a reliable regional pedicled flap with local color match and simplified surgical execution without requiring microvascular anastomoses.
This retrospective observational cohort study aims to compare patients who received SIPF versus RFFF for tongue reconstruction. The primary objective is to evaluate health-related quality of life outcomes using the validated University of Washington Quality of Life Questionnaire version 4 (UW-QOL v4), alongside evaluating postoperative surgical outcomes and donor site morbidity.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Assuit
-
Asyut, Assuit, Egypt
- Faculty of Dental Medicine, Al-Azhar University (Assiut Branch)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult patients (aged 18 years or older) diagnosed with squamous cell carcinoma of the tongue requiring partial or total glossectomy.
- Indication for immediate soft tissue reconstruction using either Submental Island Pedicled Flap (SIPF) or Radial Forearm Free Flap (RFFF).
- Patients eligible and cleared for major surgical resection and flap reconstruction under general anesthesia.
- Patient's informed consent to participate in the study and complete follow-up evaluations.
Exclusion Criteria:
- History of previous radiation therapy or surgical intervention in the head and neck region.
- Clinical or radiological evidence of nodal metastasis in level I submental lymph nodes (for SIPF candidates).
- Severe systemic comorbidities precluding major surgery or prolonged general anesthesia (ASA class IV or higher).
- Distance or inability to commit to the 12-month postoperative follow-up schedule and quality of life assessments.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
SIPF Group
Patients who underwent tongue reconstruction using Submental Island Pedicled Flap following tongue cancer resection.
|
Surgical reconstruction of tongue defect following oncological resection using a pedicled submental island flap.
|
|
RFFF group
Patients who underwent tongue reconstruction using Radial Forearm Free Flap following tongue cancer resection.
|
Surgical reconstruction of tongue defect following oncological resection using a microvascular radial forearm free flap.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
12-Month Baseline-Adjusted Composite Quality of Life (UW-QOL v4)
Time Frame: 12 months post operatively
|
Unweighted composite score calculated as the mean of all 12 domains of the University of Washington Quality of Life Questionnaire version 4 (UW-QOL v4), evaluated at 12 months postoperatively and adjusted for baseline composite score using analysis of covariance (ANCOVA).
Scores range from 0 to 100, where higher scores indicate better quality of life.
|
12 months post operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6-Month Baseline-Adjusted Composite Quality of Life (UW-QOL v4)
Time Frame: 6 months post operatively
|
Unweighted composite score of the 12 UW-QOL v4 domains evaluated at 6 months postoperatively and adjusted for baseline composite score using ANCOVA.
Scores range from 0 to 100.
|
6 months post operatively
|
|
Operative time
Time Frame: Day of surgery (intraoperative)
|
Total duration of surgery measured in hours from initial skin incision to final closure.
|
Day of surgery (intraoperative)
|
|
Length of hospital stay
Time Frame: From date of surgery to hospital discharge. Up to 30 days
|
Total duration of inpatient hospital admission measured in days from surgery until discharge.
|
From date of surgery to hospital discharge. Up to 30 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mohamed Serag Attia, MSc, Al-Azhar University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AUAREC20240007-3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.